The figure below shows total musculoskeletal costs in comparison to other major chronic conditions for a collection of large employers in the HCMS Group Research Reference Database (RRDb). Musculoskeletal costs rank among the highest with respect to comorbidities and disability costs, with co-morbidity costs nearly twice that of condition-specific costs.
Figure 2: Top Condition Comorbidity Analysis
The co-morbidity analysis emphasizes the need to treat the individual, not a specific condition. In the case of musculoskeletal conditions, common comorbidities include obesity, diabetes, and hypertension. Treating theses diseases individually is therefore inefficient; an effective treatment plan needs to address the individual.